WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'1301 Infant (under 12 months) mortality rate: 262
GDP / capita (US$): 14'2121 Child (under 5 years) mortality rate: 312

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 10'649  10'528  10'406  10'281  10'155  8'563  7'184  5'809 
Births 215  216  217  218  219  216  214  200 
Surviving infants 210  211  212  213  213  208  203  184 
Pop. less than 5 years 1'060  1'062  1'064  1'063  1'062  1'020  988  885 
Pop. less than 15 years 3'156  3'154  3'148  3'139  3'127  3'001  2'780  2'481 
Female 15-49 years 2'766  2'738  2'712  2'685  2'658  2'216  1'778  1'368 

Number of reported cases

(Click for retrospective incidence data for Dominican Republic (the))
Diphtheria
ChartChart
  52  27  187 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  253  3'477  9'760 
Mumps
ChartChart
  1'833  2'087  1'784  498  2'760 
Pertussis
ChartChart
  26  69  98  17  11  40  227  558 
Polio*
ChartChart
  11  148 
Rubella
ChartChart
  818 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  12  14 
Tetanus (total)**
ChartChart
  46  37  45  55  40  25  56  113 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Dominican Republic (the))
Vaccine year result method % card seen                                                
BCG 2013  94  MICS   71  99*  99*  99*  99  99*  90  68  29 
DTP1 2013  93  MICS   71  98  99  99*  91  93 
DTP3 2013  64  MICS   71  87  85  91  83  85  78  69  36 
DTP4          74  73  78 
IPV1          96  78 
HepB_BD          79  82  78  74 
HepB3 2013  61  MICS   71  80  81  89  80  74  68 
Hib3 2013  60  MICS   71  73  76  87  75  70 
JapEnc         
MCV1          85  90  88  83  88  88  96  30 
MCV2         
MenA         
PCV1          89  75  94  88 
PCV2          80  61  81  21 
PCV3 2013  MICS   71  30  22  27 
Pol3 2013  71  MICS   71  82  87  90  82  85  67  90  46 
Rota1          87  94  96  81  59 
RotaC 2013  10  MICS   71  75  83  86  69  34 
RCV1          90  87  83  88 
TT2plus 2012  78  DHS   70  87  51  86  87  90  25 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Dominican Republic (the))
BCG
ChartChart
  99  99  99  99  99  90  70  29 
DTP1
ChartChart
  98  99  95  91  92  91  87  61 
DTP3
ChartChart
  87  85  91  83  85  78  69  36 
HepB3
ChartChart
  80  81  89  80  74  68 
HepB_BD
ChartChart
  64  64  67  63  59 
Hib3
ChartChart
  73  76  87  75  70 
IPV1
  96 
MCV1
ChartChart
  85  90  88  83  88  85  70  30 
MCV2
ChartChart
 
PCV3
ChartChart
  30  22  27 
Pol3
ChartChart
  82  87  90  82  85  71  90  46 
RCV1
ChartChart
  85  90  88  83  88 
RotaC
ChartChart
  75  83  86  69 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 157  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 43
From 80 to 89% 16
From 50 to 79% 27
Less than 50% 13
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 2, 4, 6, 18 months; 4 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB_Adult 1st contact; +1, +6 months; Yes risk groups
HepB_Pediatric birth; Yes
HPV 9-10 years; +6 months; Yes From 2017
Influenza_Adult >= 60 years; Yes and pregnant wome, health care workers, adults with chronic diseases
Influenza_Pediatric 6-23 months; Yes and children with chronic diseases
IPV 2 months; Yes
MMR 12 months; Yes
MR >= 2 years; Yes and outbreaks
OPV 4, 6, 18 months; 4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Rabies Yes post exposure
Rotavirus 2, 4 months; Yes
Td 1st contact; + 1 month; +6 months; +1, +1, +10 year; Yes From 7 years
YF Yes travelers

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  No  No  No  Yes  Yes 
What years does the MYP cover? number 2016-2020  2016-2019        2010-2015  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number       68      75 

System performance

Total Nº districts in country number 157  157  155  155  155  155  155 
Nº districts with DTP3 coverage >=80% number 93  88  102  76  75  68  93 
% of districts with DTP3 coverage >=80% From 0 to 100% 59  56  66  49  48  44  60 
Nº districts with measles (MCV1) coverage >=95% number 49  53  53  28  46  47  38 
% of districts with MCV1 coverage >=95% From 0 to 100% 31  34  34  18  30  30  25 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  94  94  99  99  45  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No    No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.